{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:31:37Z","timestamp":1765546297977},"reference-count":38,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2018.8390","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T11:36:15Z","timestamp":1515411375000},"source":"Crossref","is-referenced-by-count":9,"title":["miR\u2011378a enhances the sensitivity of liver cancer to sorafenib by targeting VEGFR, PDGFR\u03b2 and c\u2011Raf"],"prefix":"10.3892","author":[{"given":"Hongxia","family":"Fu","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jicai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongshan","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Danjiangkou First Hospital, Danjiangkou, Hubei 442700, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuying","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengqin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,1,8]]},"reference":[{"key":"key20200713224357_b1-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"key20200713224357_b2-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global Cancer Statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"Ca Cancer J Clin"},{"key":"key20200713224357_b3-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/aje\/kwj104","article-title":"Maternal and infant birth characteristics and hepatoblastoma","volume":"163","author":"McLaughlin","year":"2006","journal-title":"Am J Epidemiol"},{"key":"key20200713224357_b4-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/HMER.S89997","article-title":"Unresectable hepatoblastoma: Current perspectives","volume":"9","author":"Trobaugh-Lotrario","year":"2017","journal-title":"Hepatic Med"},{"key":"key20200713224357_b5-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/145749691110000105","article-title":"Treatment options in hepatocellular carcinoma today","volume":"100","author":"Livraghi","year":"2011","journal-title":"Scand J Surg"},{"key":"key20200713224357_b6-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: A phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"key20200713224357_b7-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.redox.2015.07.010","article-title":"Regulation of cell death receptor S-nitrosylation and apoptotic signaling by sorafenib in hepatoblastoma cells","volume":"6","author":"Rodr\u00edguez-Hern\u00e1ndez","year":"2015","journal-title":"Redox Biology"},{"key":"key20200713224357_b8-mmr-17-03-4581","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26701","article-title":"Complete remission of refractory hepatoblastoma after liver transplantation in a child with sorafenib monotherapy: A new hope?","author":"Shanmugam","year":"2017","journal-title":"Pediatric Blood Cancer"},{"key":"key20200713224357_b9-mmr-17-03-4581","unstructured":"DazertE.ColombiMBoldanovaTMoesSAdametzDQuagliataLRothVTerraccianoLHeimMHJenoePHallMNQuantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patientProc Natl Acad Sci USA11313811386201610.1073\/pnas.1523434113267879124747770"},{"key":"key20200713224357_b10-mmr-17-03-4581","first-page":"1709","article-title":"Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS\/RAF\/MAPK and WNT\/\u03b2-catenin pathways","volume":"34","author":"Galuppo","year":"2014","journal-title":"Anticancer Res"},{"key":"key20200713224357_b11-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"key20200713224357_b12-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"key20200713224357_b13-mmr-17-03-4581","first-page":"2254","article-title":"Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC","volume":"7","author":"Song","year":"2015","journal-title":"Am J Transl Res"},{"key":"key20200713224357_b14-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"e88393","DOI":"10.1371\/journal.pone.0088393","article-title":"MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"key20200713224357_b15-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.biopha.2013.09.005","article-title":"miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC)","volume":"68","author":"Gao","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"key20200713224357_b16-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.3892\/ol.2016.5102","article-title":"Regulatory network analysis of genes and microRNAs in human hepatoblastoma","volume":"12","author":"He","year":"2016","journal-title":"Oncol Lett"},{"key":"key20200713224357_b17-mmr-17-03-4581","unstructured":"CairoSWangYde Reyni\u00e8sADuroureKDahanJRedonMJFabreMMcClellandMWangXWCroceCMBuendiaMAStem cell-like micro-RNA signature driven by Myc in aggressive liver cancerProc Natl Acad Sci USA1072047120476201010.1073\/pnas.1009009107210599112996672"},{"key":"key20200713224357_b18-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s13277-015-3996-8","article-title":"miR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo","volume":"37","author":"Chen","year":"2016","journal-title":"Tumor Biol"},{"key":"key20200713224357_b19-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1080\/15476286.2016.1239008","article-title":"miR-378a-3p promotes differentiation and inhibits proliferation of myoblasts by targeting HDAC4 in skeletal muscle development","volume":"13","author":"Wei","year":"2016","journal-title":"RNA Biol"},{"key":"key20200713224357_b20-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ebiom.2016.01.035","article-title":"miR-378 activates the pyruvate-pep futile cycle and enhances lipolysis to ameliorate obesity in mice","volume":"5","author":"Zhang","year":"2016","journal-title":"EBioMedicine"},{"key":"key20200713224357_b21-mmr-17-03-4581","volume-title":"TNM classification of malignant tumors","author":"Sobin","year":"2010","edition":"7th"},{"key":"key20200713224357_b22-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713224357_b23-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.3748\/wjg.v19.i33.5439","article-title":"Epigenetics of hepatocellular carcinoma: Role of microRNA","volume":"19","author":"Khare","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key20200713224357_b24-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00535-014-0932-4","article-title":"Antitumor function of microRNA-122 against hepatocellular carcinoma","volume":"49","author":"Nakao","year":"2014","journal-title":"J Gastroenterol"},{"key":"key20200713224357_b25-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.biopha.2016.07.037","article-title":"miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6","volume":"83","author":"Zhu","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"key20200713224357_b26-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.3892\/or.2015.3936","article-title":"miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients","volume":"33","author":"Huang","year":"2015","journal-title":"Oncol Rep"},{"key":"key20200713224357_b27-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s12094-016-1582-1","article-title":"miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC","volume":"19","author":"Chang","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"key20200713224357_b28-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"281756","DOI":"10.1155\/2015\/281756","article-title":"The role of miR-378a in metabolism, angiogenesis, and muscle biology","volume":"2015","author":"Krist","year":"2015","journal-title":"Int J Endocrinol"},{"key":"key20200713224357_b29-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbrc.2014.12.055","article-title":"miR-378a-3p enhances adipogenesis by targeting mitogen-activated protein kinase 1","volume":"457","author":"Huang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713224357_b30-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ejca.2013.12.010","article-title":"Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer","volume":"50","author":"Li","year":"2014","journal-title":"Eur J Cancer"},{"key":"key20200713224357_b31-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1186\/1471-2407-14-880","article-title":"Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members","volume":"14","author":"Megiorni","year":"2014","journal-title":"BMC Cancer"},{"key":"key20200713224357_b32-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"13170","DOI":"10.1038\/srep13170","article-title":"miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A","volume":"5","author":"Ikeda","year":"2015","journal-title":"Sci Rep"},{"key":"key20200713224357_b33-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3892\/ijo.2015.2977","article-title":"The novel anti-neuroblastoma agent PF403, inhibits proliferation and invasion in vitro and in brain xenografts","volume":"47","author":"Li","year":"2015","journal-title":"Int J Oncol"},{"key":"key20200713224357_b34-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"27187","DOI":"10.18632\/oncotarget.4551","article-title":"By inhibiting Ras\/Raf\/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis","volume":"6","author":"Gao","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713224357_b35-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11060-012-0996-z","article-title":"Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma","volume":"111","author":"Moreno","year":"2013","journal-title":"J Neurooncol"},{"key":"key20200713224357_b36-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.humpath.2008.06.004","article-title":"High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer","volume":"39","author":"Ghosh","year":"2008","journal-title":"Hum Pathol"},{"key":"key20200713224357_b37-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1002\/cncr.28864","article-title":"The MAPK pathway across different malignancies: A new perspective","volume":"120","author":"Burotto","year":"2014","journal-title":"Cancer"},{"key":"key20200713224357_b38-mmr-17-03-4581","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.taap.2015.05.010","article-title":"Requirement of ER\u03b1 and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK\/ERK pathway in human breast cancer MCF-7 cells","volume":"287","author":"Song","year":"2015","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T22:55:10Z","timestamp":1594680910000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2018.8390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,8]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3892\/mmr.2018.8390","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,8]]}}}